AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)

CUSIP: 00901B105

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,129,058
Total 13F shares
7,205,272
Share change
-215,083
Total reported value
$15,488,490
Price per share
$2.15
Number of holders
34
Value change
-$493,510
Number of buys
17
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
MORGAN STANLEY
13F
Company
3.7%
2,505,954
$5,689,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
2.9%
1,926,399
$4,373,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
1.5%
979,042
$2,223,000 31 Mar 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.71%
478,759
$1,087,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.52%
351,750
$798,000 31 Mar 2021
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.4%
271,000
$615,000 31 Mar 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.17%
116,800
$265,000 31 Mar 2021
13F
Verition Fund Management LLC
13F
Company
0.16%
108,000
$245,000 31 Mar 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.15%
103,283
$234,000 31 Mar 2021
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.11%
74,790
$170,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.1%
67,746
$154,000 31 Mar 2021
13F
HighTower Advisors, LLC
13F
Company
0.09%
63,095
$143,000 31 Mar 2021
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.07%
46,679
$106,000 31 Mar 2021
13F
SeaCrest Wealth Management, LLC
13F
Company
0.06%
43,563
$99,000 31 Mar 2021
13F
Rockefeller Capital Management L.P.
13F
Company
0.06%
40,000
$90,000 31 Mar 2021
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.06%
38,500
$88,000 31 Mar 2021
13F
Virtu Financial LLC
13F
Company
0.04%
29,484
$67,000 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
0.04%
25,266
$57,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.03%
20,316
$47,000 31 Mar 2021
13F
Engineers Gate Manager LP
13F
Company
0.03%
17,900
$41,000 31 Mar 2021
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.03%
17,000
$39,000 31 Mar 2021
13F
LPL Financial LLC
13F
Company
0.02%
16,500
$37,000 31 Mar 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
15,000
$34,000 31 Mar 2021
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0.02%
14,000
$32,000 31 Mar 2021
13F
Community Bank, N.A.
13F
Company
0.02%
13,226
$30,000 31 Mar 2021
13F
Traynor Capital Management, Inc.
13F
Company
0.02%
11,777
$26,000 31 Mar 2021
13F
Lehman & Derafelo Financial Resources LLC
13F
Company
0.02%
11,100
$25,000 31 Mar 2021
13F
Steward Partners Investment Advisory, LLC
13F
Company
0.01%
5,000
$11,350 31 Mar 2021
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
5,000
$11,000 31 Mar 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
3,765
$9,000 31 Mar 2021
13F
Global Wealth Management Investment Advisory, Inc.
13F
Company
0%
600
$1,000 31 Mar 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
406
$1,000 31 Mar 2021
13F
American Portfolios Advisors
13F
Company
0%
228
$518 31 Mar 2021
13F

Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q2 2021

As of 30 Jun 2021, AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,205,272 shares. The largest 10 holders included MORGAN STANLEY, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, and Verition Fund Management LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
32
Q2 2021 holders
34
Holder diff
2
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.